Nasdaq · Industrials
CROSS COUNTRY HEALTHCARE INC (CCRN)
As-reported financials and recent SEC filings for CROSS COUNTRY HEALTHCARE INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.05B
Net income
$-94.9M
Net margin
-9.0%
Diluted EPS
$-2.93
ROE
-29.4%
P/E (TTM)
—
Market cap
$427.1M
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.05B | $1.34B | $2.02B | $2.80B | $1.68B |
| Gross profit | — | — | — | — | — |
| Operating income | $-84.4M | $-16.9M | $112.7M | $269.9M | $139.3M |
| Net income | $-94.9M | $-14.6M | $72.6M | $188.5M | $132.0M |
| Diluted EPS | $-2.93 | $-0.44 | $2.05 | $4.95 | $3.53 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-23
View on EDGAR →DEFM14A2026-06-15
View on EDGAR →PREM14A2026-06-03
View on EDGAR →SCHEDULE 13G2026-05-14
View on EDGAR →10-Q2026-05-08
View on EDGAR →8-K2026-05-07
View on EDGAR →DEFA14A2026-05-07
View on EDGAR →DEFA14A2026-05-07
View on EDGAR →Go deeper on CCRN
Search CROSS COUNTRY HEALTHCARE INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.